Akanda (AKAN) Competitors $1.75 +0.03 (+1.74%) Closing price 02/21/2025 03:58 PM EasternExtended Trading$1.75 0.00 (0.00%) As of 02/21/2025 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrends AKAN vs. BGXX, CHRO, RLMD, NLSP, AYTU, APM, AIM, BFRI, KLTO, and INDPShould you be buying Akanda stock or one of its competitors? The main competitors of Akanda include Bright Green (BGXX), Chromocell Therapeutics (CHRO), Relmada Therapeutics (RLMD), NLS Pharmaceutics (NLSP), Aytu BioPharma (AYTU), Aptorum Group (APM), AIM ImmunoTech (AIM), Biofrontera (BFRI), Klotho Neurosciences (KLTO), and Indaptus Therapeutics (INDP). These companies are all part of the "pharmaceutical products" industry. Akanda vs. Bright Green Chromocell Therapeutics Relmada Therapeutics NLS Pharmaceutics Aytu BioPharma Aptorum Group AIM ImmunoTech Biofrontera Klotho Neurosciences Indaptus Therapeutics Bright Green (NASDAQ:BGXX) and Akanda (NASDAQ:AKAN) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, media sentiment, valuation, dividends, community ranking and profitability. Does the MarketBeat Community believe in BGXX or AKAN? Bright Green and Akanda both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformBright GreenN/AN/AAkandaN/AN/A Which has more risk and volatility, BGXX or AKAN? Bright Green has a beta of -0.26, suggesting that its share price is 126% less volatile than the S&P 500. Comparatively, Akanda has a beta of 1.66, suggesting that its share price is 66% more volatile than the S&P 500. Does the media refer more to BGXX or AKAN? In the previous week, Bright Green's average media sentiment score of 0.00 equaled Akanda'saverage media sentiment score. Company Overall Sentiment Bright Green Neutral Akanda Neutral Which has better valuation and earnings, BGXX or AKAN? Bright Green has higher earnings, but lower revenue than Akanda. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBright GreenN/AN/A-$13.13M-$0.06-0.65Akanda$2.16M1.16-$32.28MN/AN/A Is BGXX or AKAN more profitable? Akanda's return on equity of 0.00% beat Bright Green's return on equity.Company Net Margins Return on Equity Return on Assets Bright GreenN/A -88.37% -55.30% Akanda N/A N/A N/A Do insiders & institutionals believe in BGXX or AKAN? 7.8% of Bright Green shares are held by institutional investors. Comparatively, 1.0% of Akanda shares are held by institutional investors. 62.6% of Bright Green shares are held by insiders. Comparatively, 20.4% of Akanda shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryAkanda beats Bright Green on 4 of the 7 factors compared between the two stocks. Get Akanda News Delivered to You Automatically Sign up to receive the latest news and ratings for AKAN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AKAN vs. The Competition Export to ExcelMetricAkandaMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.45M$1.16B$5.84B$9.15BDividend YieldN/AN/A4.75%3.85%P/E RatioN/A35.7826.1519.13Price / Sales1.165.72435.3370.72Price / CashN/A10.4038.0134.83Price / Book-0.021.927.644.62Net Income-$32.28M-$53.22M$3.19B$245.94M7 Day Performance-0.51%-5.53%-2.11%-2.62%1 Month Performance10.06%-1.92%-0.49%-2.15%1 Year Performance-92.67%-13.79%16.44%12.95% Akanda Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AKANAkandaN/A$1.75+1.7%N/A-92.7%$2.45M$2.16M0.00110Positive NewsBGXXBright GreenN/A$0.05+25.0%N/A-79.5%$9.56MN/A-0.832Gap UpCHROChromocell TherapeuticsN/A$1.57+22.7%N/A-64.9%$9.47MN/A0.004RLMDRelmada Therapeutics4.3054 of 5 stars$0.31-0.2%$4.25+1,278.1%-94.8%$9.30MN/A-0.1110Gap DownNLSPNLS PharmaceuticsN/A$2.57+37.4%N/A+364.1%$9.25MN/A0.006Gap UpHigh Trading VolumeAYTUAytu BioPharma1.0241 of 5 stars$1.50-3.2%N/A-55.0%$9.22M$79.76M-1.22160High Trading VolumeAPMAptorum Group0.4972 of 5 stars$1.75+43.4%N/A-38.1%$9.07M$430,000.000.0030Gap UpAIMAIM ImmunoTech1.7411 of 5 stars$0.14-3.5%$2.75+1,835.3%-67.1%$9.06M$200,000.00-0.3020BFRIBiofrontera2.6469 of 5 stars$1.15flat$7.00+508.7%+13.6%$8.91M$34.07M-0.5170News CoveragePositive NewsKLTOKlotho NeurosciencesN/A$0.33-8.8%N/AN/A$8.80MN/A0.00N/AGap UpINDPIndaptus Therapeutics3.1036 of 5 stars$0.83+4.6%$8.50+921.6%-52.9%$8.49MN/A-0.496Gap Up Related Companies and Tools Related Companies BGXX Competitors CHRO Competitors RLMD Competitors NLSP Competitors AYTU Competitors APM Competitors AIM Competitors BFRI Competitors KLTO Competitors INDP Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AKAN) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredThis quote from Elon says it all… (AI Breakthrough)MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | Sponsored2025 AI Blueprint features Nvidia’s march to $5 trillionNvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredHas Trump finally met his match?A new Chinese AI software called "DeepSeek" is sending shockwaves through the market. It's advanced enough ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akanda Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akanda With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
